Oncology Hematology Associates
Oncology Hematology Associates is a physician-owned community oncology and hematology practice founded in 1979, operating three clinics across the Missouri Ozarks (Springfield, Monett, Lebanon) and delivering integrated cancer care, in-house pharmacy, specialty infusion, BiTE therapy, and clinical trial services as an American Oncology Network affiliate.
- Company typePrivate
- Founded1979
- HeadquartersSpringfield, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Oncology Hematology Associates does
Oncology Hematology Associates (OHA) is a physician-owned community oncology and hematology practice founded in 1979 and headquartered in Springfield, Missouri. The practice delivers comprehensive cancer care across three clinic locations — Springfield (primary hub at 3850 S National Ave), Monett, and Lebanon (opened November 2022) — serving patients throughout the Missouri Ozarks. Core clinical services include medical oncology (chemotherapy, immunotherapy, targeted therapy, oral chemotherapy), hematology for blood cancers and autoimmune disorders, bispecific T-cell engager (BiTE) therapy added through the AON network in July 2025, and specialty infusion for chronic conditions such as Crohn's disease, multiple sclerosis, and rheumatoid arthritis.
OHA operates an integrated, vertically-stacked care delivery model that combines in-house specialty pharmacy with 24/7 pharmacist availability and home delivery, a centralized pathology laboratory using Lean and Six Sigma process improvements, on-site infusion centers, and an FDA-cleared DigniCap scalp cooling system. Patient support layers include care coordination and navigation, financial counseling with insurance assistance, clinical trial access across Phase I-IV, telehealth via AON.Doxy.me, and the Hope for the Journey Foundation (OHA-founded) for non-medical expense relief. The practice is staffed by four board-certified medical oncologists/hematologists — Jiantao Ding MD, Brooke Gillett DO, Robert Ellis MD FACP, and Roger Holden MD PhD — plus five advanced practitioners (Donna Powers NP, Candi Jordan APRN, Christine Czachowski APRN, Madison Pendergraft APRN, Megan Brattin APRN).
OHA joined American Oncology Network (AON) in November 2019, gaining access to AON's oral oncolytic pharmacy, centralized pathology, telehealth platform, and BiTE therapy network spanning more than 40 clinics across 18 states and Washington D.C. Despite the affiliation, the practice retains physician leadership and brand identity. Revenue is generated through fee-for-service patient billing across all major insurance categories (Medicare, Medicaid, commercial), with documented community oncology cost advantage of 34-42% below hospital outpatient chemotherapy settings and patient satisfaction scores of 96.1% and above. Academic partnerships with MD Anderson, Mayo Clinic, Cleveland Clinic, and Barnes-Jewish Hospital support referral continuity and standard-of-care alignment. The practice maintains referral and community-partnership channels including CanCare (peer survivor support) and the Hope for the Journey Foundation.
Oncology Hematology Associates firmographics
Firmographics- Name
- Oncology Hematology Associates
- Legal name
- Oncology Hematology Associates
- Website
- https://ohaclinic.com
- Company type
- Private
- Founded year
- 1979
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Oncology Hematology Associates is a physician-owned community oncology and hematology practice founded in 1979, operating three clinics across the Missouri Ozarks (Springfield, Monett, Lebanon) and delivering integrated cancer care, in-house pharmacy, specialty infusion, BiTE therapy, and clinical trial services as an American Oncology Network affiliate.
- Ownership category
- akta.pro rank
Oncology Hematology Associates industry classification
Industry- Product category
- Community Oncology and Hematology Services
- NAICS
- Offices of Physicians (62111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Medical Oncology (HLAKAFAB)
- akta.pro secondary industry
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
Keywords
Where Oncology Hematology Associates is headquartered
LocationHeadquarters
- HQ city
- Springfield
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Oncology Hematology Associates business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Supply Chain, Marketing or Sales, Technology or R&D
Revenue model
- Patient Care Services: Revenue generated from providing oncology and hematology medical services to patients. Services include medical oncology (chemotherapy, immunotherapy, targeted therapy), hematology, specialty infusion, pathology, pharmacy, and clinical trials. Billed through insurance including Medicare/Medicaid and private payers.
- Specialty Pharmacy Services: In-house specialty pharmacy providing oral oncolytic medications with home delivery. Revenue from medication dispensing and delivery services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Standard patient billing based on insurance coverage |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Oncology Hematology Associates product offering
Product offeringCore offering
Oncology Hematology Associates is a community-based oncology and hematology medical practice that delivers cancer treatment (chemotherapy, immunotherapy, targeted therapy, BiTE therapy), hematology services, specialty infusion, in-house pharmacy, pathology, clinical trials, care coordination, financial counseling, and telehealth to patients across Missouri. The practice operates as a unified care model across three clinic locations, integrating ancillary services (lab, pathology, pharmacy, infusion) with physician-led treatment.
Product overview
Oncology Hematology Associates (OHA) is a community oncology/hematology healthcare practice that provides a comprehensive range of cancer and blood disorder treatment services. The practice operates as a unified care model with core medical oncology and hematology services complemented by specialized treatment offerings including BiTE therapy, specialty infusion services, pathology, and an in-house pharmacy. Patient support services include care coordination and navigation, clinical trials, financial support, telehealth, and the Hope for the Journey Foundation. OHA has been serving the region since 1979 and currently operates three clinic locations in Springfield, Monett, and Lebanon, Missouri.
Differentiator
Problem solved
Functional benefit
Brands
- Hope for the Journey Foundation: A foundation founded by OHA to help adult cancer patients and their families with non-medical expenses such as utility bills, groceries, mortgage payments, and affordable housing.
- CanCare Partnership
Products and services
- Medical Oncology Chemotherapy, biological agents, targeted therapies, immunotherapy, and oral chemotherapy to treat bladder, brain, breast, cervical, colorectal, head and neck, hematologic, kidney, liver, lung, melanoma, pancreatic, prostate, and sarcoma cancers. Designed for adult oncology patients in the Ozarks region.
- Hematology Specialized diagnosis and treatment of blood cancers and autoimmune disorders including lymphoma, leukemia, myelodysplastic syndromes, multiple myeloma, myeloproliferative syndromes, aplastic anemia, and other hematological malignancies. For adult patients with malignant and non-malignant blood disorders.
- BiTE Therapy Bispecific antibody therapy that links T cells to cancer cells, boosting immune response with precision and expanded treatment options for acute lymphoblastic leukemia, uveal melanoma, diffuse large B-cell lymphoma, follicular lymphoma, multiple myeloma, and extensive-stage small cell lung cancer. Targeted at oncology patients with hard-to-treat hematologic malignancies and solid tumors.
- Specialty Infusion Services Infusion therapies for chronic diseases including anemia, Crohn's disease, multiple sclerosis, and rheumatoid arthritis using medications such as Actemra, Benlysta, Entyvio, Immunoglobulins, and Ocrevus. Delivered in partnership with rheumatology, allergy, immunology, dermatology, pulmonology, gastroenterology, neurology, and benign hematology specialists. For patients requiring ongoing infusion therapy outside a hospital setting.
- Pathology Centralized pathology laboratory providing complete diagnostic testing with a state-of-the-art facility staffed by specialized laboratory scientists, hematopathologists, and surgical pathologists using Lean and Six Sigma process improvements. Serves OHA's own oncology and hematology patients as well as referral-based diagnostic needs.
- In-House Specialty Pharmacy Specialty pharmacy dispensing oral oncolytic medications with 24/7 pharmacist availability, insurance assistance, FedEx home delivery, financial assistance, and clinical support. For OHA oncology patients requiring oral cancer therapy.
- DigniCap Scalp Cooling FDA-cleared scalp cooling system with a patented cooling cap and liquid coolant circulation that delivers consistent, controlled cooling to reduce hair loss during chemotherapy. For oncology patients concerned about chemotherapy-induced alopecia.
- Care Coordination and Navigation Oncology clinicians guide patients through the care journey with symptom monitoring, medication education, nutritional guidance, barrier identification, personalized care planning, and survivorship support. For oncology patients and families navigating complex treatment.
- Clinical Trials Opportunity to participate in approved and exploratory therapies through Phase I, II, III, and IV clinical trials without long-distance travel. For oncology patients seeking access to emerging therapies locally.
- Financial Support and Counseling Financial counselors assist with insurance issues and connect patients with assistance programs including Patient Access Network Foundation, Leukemia and Lymphoma Society, and pharmaceutical patient assistance programs. For oncology patients managing the cost of cancer treatment.
- Telehealth Services Virtual video visits via the AON.Doxy.me platform allowing patients to meet with physicians, advanced practitioners, nurses, or dietitians from home or any private location, reducing travel costs and providing convenient care access. For OHA patients who cannot travel or wish to reduce in-person visits.
- Hope for the Journey Foundation Foundation offering financial assistance with non-medical expenses such as utility bills, groceries, mortgage payments, and affordable housing for adult cancer patients in Springfield, Monett, and Lebanon areas. Funds raised stay local.
Quantifiable outcome
- 96.1%+ patient satisfaction scores
- +1 more outcomes
Companies that use Oncology Hematology Associates
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
Oncology Hematology Associates technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature5 records
Oncology Hematology Associates partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- American Oncology Network (AON) - BiTE Therapy NetworkcoreAs part of AON network, OHA offers bispecific T-cell Engager (BiTE) therapy at their clinic. AON has more than 40 clinics across 18 states and Washington D.C. offering BiTE therapies for acute lymphoblastic leukemia, uveal melanoma, diffuse large B-cell lymphoma, follicular lymphoma, multiple myeloma, and extensive-stage small cell lung cancer.
- American Oncology Network (AON)coreOHA joined AON in November 2019. AON is an alliance of physicians and healthcare leaders ensuring the long-term success of community oncology. Through the affiliation, OHA expanded services including enhanced technology, oral oncolytic outpatient pharmacy with home delivery, and centralized pathology services.
- CanCareminorCanCare is a nonprofit cancer support organization providing free, personal support to patients and families. Connects patients with trained volunteer survivors and caregivers matched to their situation. Available to OHA patients and their loved ones at any stage of the cancer journey.
- Hope for the Journey FoundationminorOHA founded and supports Hope for the Journey Foundation to help adult cancer patients with non-medical expenses. Funds raised stay local in Springfield, Monett, and Lebanon areas. Works with Community Foundation of the Ozarks for administration.
- MD Anderson Cancer CenterminorAcademic center partnership for ensuring best, most current standard of patient care. One of several major academic centers of excellence that OHA partners with.
- Mayo ClinicminorAcademic center partnership for ensuring best, most current standard of patient care.
- Barnes-Jewish HospitalminorAcademic center partnership for ensuring best, most current standard of patient care.
- Cleveland ClinicminorAcademic center partnership for ensuring best, most current standard of patient care.
Scale indicators3 records
Recent moves8 records
Expansion highlights5 records
Oncology Hematology Associates competitors and assessment
Company assessmentDirect peers
- American Oncology Network: OHA's parent network and most direct peer. AON is an alliance of community oncology practices offering the same integrated services (pharmacy, pathology, BiTE therapy, clinical trials) across 40+ clinics in 18 states; OHA operates as an AON partner practice with shared infrastructure and protocols.
- Tennessee Oncology: Large independent community oncology practice serving Tennessee and surrounding states with medical oncology, hematology, infusion, specialty pharmacy, and clinical research. OneOncology founding member with comparable integrated model to OHA.
- OneOncology: National platform partnering with independent community oncology practices like Tennessee Oncology, providing practice management, technology, and shared services. Direct strategic peer to AON and a potential affiliation alternative for OHA.
- Florida Cancer Specialists & Research Institute: Largest independent community oncology practice in the U.S., offering medical oncology, hematology, infusion, clinical trials, and specialty pharmacy across Florida. Highly comparable business model to OHA with vertically integrated services and physician ownership.
- Compass Oncology: Community oncology practice with multiple clinic locations across Oregon and southwest Washington offering medical oncology, hematology, infusion, and clinical research. Comparable to OHA as a multi-site independent community oncology practice.
- Regional Cancer Care Associates (RCCA): Large community oncology practice serving New Jersey, Connecticut, Maryland, and the Washington D.C. area with medical oncology, hematology, infusion, and clinical trials. Comparable multi-site independent practice model with physician ownership.
- Northwest Medical Specialties: Independent community oncology and infectious disease practice serving the Puget Sound region with multiple clinic locations offering chemotherapy, immunotherapy, specialty infusion, and clinical trials. Similar scale and integrated service mix to OHA.
- Texas Oncology / US Oncology Network: Largest community oncology network in the U.S., operating hundreds of sites across Texas and additional states through McKesson's US Oncology Network. Closest analog to AON in scale and service breadth (pharmacy, pathology, clinical trials).
- Rocky Mountain Cancer Centers: Large community oncology practice with multiple locations across Colorado offering medical oncology, hematology, radiation oncology, infusion, and clinical trials. US Oncology Network affiliate and direct peer in size and integrated service model.
Broad incumbents
- City of Hope (formerly Cancer Treatment Centers of America): National oncology system offering medical oncology, hematology, radiation, surgery, and clinical trials across multiple states including community sites acquired from CTCA. Comparable oncology service breadth but operates at significantly larger scale and as a health system rather than independent physician practice.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Oncology Hematology Associates social profiles
Digital presenceOncology Hematology Associates financial estimates
Financial estimateRevenue estimate
Valuation estimate
Oncology Hematology Associates leadership team
Management profileNumber of profiles
Profiles10 records
Oncology Hematology Associates subsidiaries and ownership
Company hierarchySubsidiaries1 record
Oncology Hematology Associates funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Oncology Hematology Associates M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Oncology Hematology Associates
What does Oncology Hematology Associates do?
Oncology Hematology Associates is a community-based oncology and hematology medical practice that delivers cancer treatment (chemotherapy, immunotherapy, targeted therapy, BiTE therapy), hematology services, specialty infusion, in-house pharmacy, pathology, clinical trials, care coordination, financial counseling, and telehealth to patients across Missouri. The practice operates as a unified care model across three clinic locations, integrating ancillary services (lab, pathology, pharmacy, infusion) with physician-led treatment.
Is Oncology Hematology Associates a public or private company?
Oncology Hematology Associates is a private company. It is classified as management employee owned and is currently operating.
When was Oncology Hematology Associates founded?
Oncology Hematology Associates was founded in 1979. It employs 11 to 50 people.
Where is Oncology Hematology Associates based?
Oncology Hematology Associates is headquartered in Springfield, United States, in the North America region.
How does Oncology Hematology Associates make money?
Two revenue lines are on record. Patient Care Services are the primary driver. The others are specialty Pharmacy Services.
Who are Oncology Hematology Associates's main competitors?
Direct peers on record are American Oncology Network, Tennessee Oncology, OneOncology, Florida Cancer Specialists & Research Institute, Compass Oncology, Regional Cancer Care Associates (RCCA), Northwest Medical Specialties, Texas Oncology / US Oncology Network and Rocky Mountain Cancer Centers. City of Hope (formerly Cancer Treatment Centers of America) is listed as a broad incumbent.
Does Oncology Hematology Associates have an API?
No public API is recorded for Oncology Hematology Associates.
What industry is Oncology Hematology Associates in?
Oncology Hematology Associates's product category is Community Oncology and Hematology Services. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 62111 and its SIC code is 8011.